​

STERIS (STE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

STE Stock Forecast

STERIS (STE) stock forecast, based on 13 Wall Street analysts, predicts a 12-month average price target of $269.50, with a high of $270.00 and a low of $269.00. This represents a 30.06% increase from the last price of $207.22.

$200 $214 $228 $242 $256 $270 High: $270 Avg: $269.5 Low: $269 Last Closed Price: $207.22

STE Stock Rating

STERIS stock's rating consensus is Buy, based on 13 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (84.62%), 2 Hold (15.38%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 13 0 2 11 Strong Sell Sell Hold Buy Strong Buy

STE Price Target Upside V Benchmarks

TypeNameUpside
StockSTERIS30.06%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks32.91%

Price Target Trends

1M3M12M
# Anlaysts222
Avg Price Target$269.50$269.50$269.50
Last Closing Price$207.22$207.22$207.22
Upside/Downside30.06%30.06%30.06%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 26332--8
May, 26232-18
Apr, 26232-18
Mar, 26332-19
Feb, 26332-19
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 21, 2026Jason BednarPiper Sandler$270.00$216.1824.90%30.30%
May 13, 2026Brett FishbinKeyBanc$269.00$210.8527.58%29.81%
Oct 24, 2024Jason BednarPiper Sandler$260.00$221.1517.57%25.47%
Sep 03, 2024Brett FishbinKeyBanc$265.00$241.109.91%27.88%
May 10, 2024Jason BednarPiper Sandler$225.00$225.95-0.42%8.58%
Apr 04, 2024Mike PolarkWolfe Research$245.00$216.6513.09%18.23%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 21, 2026Piper SandlerOverweightOverweighthold
May 13, 2026KeyBancOverweightOverweighthold
Jul 15, 2025Morgan StanleyEqual-WeightOverweightupgrade
May 29, 2025JefferiesHoldinitialise
May 16, 2025CitigroupOutperformOutperformhold
Feb 03, 2025Piper SandlerOverweightOverweighthold
Oct 24, 2024StephensMarket OutperformMarket Outperformhold
Oct 24, 2024Piper SandlerNeutralOverweightupgrade
Sep 03, 2024StephensMarket OutperformMarket Outperformhold
Sep 03, 2024KeyBancOverweightOverweighthold

Financial Forecast

EPS Forecast

$0 $3 $6 $9 $12 $15 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported$2.50$1.07$3.83$6.24$7.93-
Avg Forecast$7.90$8.05$8.60$9.13$10.05$10.91
High Forecast$7.96$8.10$8.66$9.15$10.23$11.99
Low Forecast$7.86$8.00$8.59$9.10$9.93$9.88
Surprise %-68.35%-86.71%-55.47%-31.65%-21.09%-

Revenue Forecast

$4B $5B $5B $6B $6B $7B Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported$4.22B$4.54B$5.14B$5.46B$5.94B-
Avg Forecast$4.55B$4.85B$5.45B$5.50B$5.82B$6.17B
High Forecast$4.57B$4.87B$5.46B$5.51B$5.85B$6.18B
Low Forecast$4.53B$4.82B$5.44B$5.47B$5.80B$6.16B
Surprise %-7.14%-6.39%-5.63%-0.68%1.98%-

Net Income Forecast

$0 $300M $600M $900M $1B $2B Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported$243.89M$107.03M$378.24M$614.64M$785.10M-
Avg Forecast$273.12M$799.67M$566.84M$907.08M$1.00B$1.09B
High Forecast$334.96M$804.62M$694.42M$909.57M$1.02B$1.19B
Low Forecast$211.29M$794.57M$439.26M$904.59M$987.06M$981.42M
Surprise %-10.70%-86.62%-33.27%-32.24%-21.64%-

STE Forecast FAQ

Is STERIS stock a buy?

STERIS stock has a consensus rating of Buy, based on 13 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that STERIS is a favorable investment for most analysts.

What is STERIS's price target?

STERIS's price target, set by 13 Wall Street analysts, averages $269.5 over the next 12 months. The price target range spans from $269 at the low end to $270 at the high end, suggesting a potential 30.06% change from the previous closing price of $207.22.

How does STERIS stock forecast compare to its benchmarks?

STERIS's stock forecast shows a 30.06% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (32.91%).

What is the breakdown of analyst ratings for STERIS over the past three months?

  • June 2026: 37.50% Strong Buy, 37.50% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 25.00% Strong Buy, 37.50% Buy, 25.00% Hold, 0% Sell, 12.50% Strong Sell.
  • April 2026: 25.00% Strong Buy, 37.50% Buy, 25.00% Hold, 0% Sell, 12.50% Strong Sell.

What is STERIS’s EPS forecast?

STERIS's average annual EPS forecast for its fiscal year ending in March 2027 is $10.91, marking a 37.58% increase from the reported $7.93 in 2026..

What is STERIS’s revenue forecast?

STERIS's average annual revenue forecast for its fiscal year ending in March 2027 is $6.17B, reflecting a 3.93% increase from the reported $5.94B in 2026.

What is STERIS’s net income forecast?

STERIS's net income forecast for the fiscal year ending in March 2027 stands at $1.09B, representing an 38.39% increase from the reported $785.1M in 2026.